Cannabis Impairment Detection Device Study

Gaize

Status: Completed

Conditions: Cannabis Intoxication

Treatments: Device: Cannabis Impairment Test

Study type: Interventional

Funder types: Industry

Identifiers

NCT07122349

22-GPHCV-01

Details and patient eligibility

About

The goal of this study is to develop a cannabis impairment detection device in adult cannabis users. The main question[s] it aims to answer are:

• Is the investigational device accurate and reliable at detecting cannabis impairment?
• is the device safe for the collection of eye movement data from cannabis intoxicated individuals? Participants will be administered a series of Drug Recognition Expert Ocular Tests via the Gaize headset following cannabis consumption.

Enrollment: 362 patients

Sex: All

Ages: 19+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adults 19, years or older, having given written informed consent to participate in the research trial and certifying that they will not drive for a period of at least 6 hours post discharge.
• Having used cannabis at least one time prior
• Having access to legal cannabis
• Normal or corrected to normal vision using either glasses or contact lenses, or surgery.

Exclusion criteria

• Enrolled in, or participated in another clinical trial within 30 days before the study
• Having a prosthetic eye
• Blood pressure greater than 160/90 mmHg and heart rate greater than 100 bpm.

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

362 participants in 1 patient group

Gaize Device

Experimental group

Treatment:

Device: Cannabis Impairment Test